Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Conducts Drug Tenders for Shanghai Market; Prices Drop 46%

publication date: Dec 7, 2018

On Thursday, China began the tendering process to supply drugs in 11 major China cities. The government wants to cut prices for generic drugs, and the process was more successful than experts predicted. China pharmas -- and multinationals -- offered their products at prices that were up to 90% lower, creating fear that winners of the tendering process might be worse off than the losers. In all, companies filed tenders to supply 31 drugs to Shanghai's hospital pharmacies. The prices dropped an average of 46% and pushed China pharma stock prices sharply lower. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital